Search results for " surfac"
Article
Biacore SPR Technology Applied to Precision Diagnostics
Sign up >>
Read this overview of Biacore™ surface plasmon resonance (SPR), a diagnostic tool to aid and simplify immunoassay reagent selection and accelerate the development of fit-for-purpose d…
Article
Reimagining Affordable Biosimilars
The sensor surfaces have been modified to allow cell-based binding to mimic real-time binding events. Cell-based binding in SPR and BLI takes into account the cell-surface expression of receptors, all…
Article
DiPIA online
Join on-demand presentations >>
Biacore surface plasmon resonance application specialists are eager to share their experience in assay design, validation, and data evaluation.
Article
The Path to High-Quality Immunoassay Reagents
How Biacore surface plasmon resonance is shaping today’s assay development and selection of diagnostic reagents.
Click here to learn more >>
Article
Epitope Binning: A Critical Step in Antibody Selection
Read about how surface plasmon resonance (SPR) is used to characterize closely related “bins” of monoclonal antibodies (mAbs) targeting the same epitope of the target protein, and how the selection …
Article
Getting it Right from the Start in the Drug Development Process
Click here to read more on how the use of surface plasmon resonance (SPR) technology may add value in drug development and how SPR assays are validated and implemented in regulated workflows.
Article
Get Acquainted with How SPR Technology is Used for Better Protein Characterization
Surface plasmon resonance (SPR) has become a go-to tool for biotherapeutic characterization, and most approved antibody therapeutics have passed through a Biacore SPR system.
Stay up-to-date wit…
Article
From Darwin to Recombinant Fc Multimers
…matography, Novel chromatography resins, Ukraine plasma market, and Novel analytical assays based on Surface Plasmon Resonance.
More than 20 posters were presented at PPB this year.
The …
Article
mAbs to Watch in 2016
Farletuzumab—Farletuzumab is an investigational humanized IgG1 antibody targeting tumor cell surface protein folate receptor alpha (FRA), which is typically overexpressed in epithelial tissue-derived …
Article
Ligand-Binding Assays and the Determination of Biosimilarity
During biosimilar development, it is necessary to demonstrate that the physicochemical properties, efficacy, and safety (e.g., immunogenicity) of the biosimilar are similar to those of the …